Press Release: Evaluate : RECOVERY COVID-19 Phase 3 Trial to Evaluate Regeneron's REGN-COV2 Investigational Antibody Cocktail in the UK

TARRYTOWN, N.Y. and OXFORD, England, Sept. 14, 2020 /PRNewswire/ -- One of the world's largest efforts to find effective COVID-19 treatments will evaluate the impact of REGN-COV2 on mortality, hospital stays, and the need for ventilation Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and...